» Articles » PMID: 22848549

DMH1, a Novel BMP Small Molecule Inhibitor, Increases Cardiomyocyte Progenitors and Promotes Cardiac Differentiation in Mouse Embryonic Stem Cells

Overview
Journal PLoS One
Date 2012 Aug 1
PMID 22848549
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The possibility of using cell-based therapeutics to treat cardiac failure has generated significant interest since the initial introduction of stem cell-based technologies. However, the methods to quickly and robustly direct stem cell differentiation towards cardiac cell types have been limited by a reliance on recombinant growth factors to provide necessary biological cues. We report here the use of dorsomorphin homologue 1 (DMH1), a second-generation small molecule BMP inhibitor based on dorsomorphin, to efficiently induce beating cardiomyocyte formation in mouse embryonic stem cells (ESCs) and to specifically upregulate canonical transcriptional markers associated with cardiac development. DMH1 differs significantly from its predecessor by its ability to enrich for pro-cardiac progenitor cells that respond to late-stage Wnt inhibition using XAV939 and produce secondary beating cardiomyocytes. Our study demonstrates the utility of small molecules to complement existing in vitro cardiac differentiation protocols and highlights the role of transient BMP inhibition in cardiomyogenesis.

Citing Articles

Aligned nanofiber scaffolds improve functionality of cardiomyocytes differentiated from human induced pluripotent stem cell-derived cardiac progenitor cells.

Ding M, Andersson H, Martinsson S, Sabirsh A, Jonebring A, Wang Q Sci Rep. 2020; 10(1):13575.

PMID: 32782331 PMC: 7419298. DOI: 10.1038/s41598-020-70547-4.


Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials.

Barreto S, Hamel L, Schiatti T, Yang Y, George V Cells. 2019; 8(12).

PMID: 31795206 PMC: 6952950. DOI: 10.3390/cells8121536.


Hereditary multiple exostoses: are there new plausible treatment strategies?.

Pacifici M Expert Opin Orphan Drugs. 2019; 6(6):385-391.

PMID: 31448184 PMC: 6707746. DOI: 10.1080/21678707.2018.1483232.


Endothelial cell clonal expansion in the development of cerebral cavernous malformations.

Malinverno M, Maderna C, Abu Taha A, Corada M, Orsenigo F, Valentino M Nat Commun. 2019; 10(1):2761.

PMID: 31235698 PMC: 6591323. DOI: 10.1038/s41467-019-10707-x.


Direct Cardiac Reprogramming: Progress and Promise.

Engel J, Ardehali R Stem Cells Int. 2018; 2018:1435746.

PMID: 29731772 PMC: 5872587. DOI: 10.1155/2018/1435746.


References
1.
Li W, Ding S . Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci. 2009; 31(1):36-45. DOI: 10.1016/j.tips.2009.10.002. View

2.
Qyang Y, Martin-Puig S, Chiravuri M, Chen S, Xu H, Bu L . The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell. 2008; 1(2):165-79. DOI: 10.1016/j.stem.2007.05.018. View

3.
Hill C, Sanchez N, Love J, Arrieta J, Hong C, Brown C . BMP2 signals loss of epithelial character in epicardial cells but requires the Type III TGFβ receptor to promote invasion. Cell Signal. 2012; 24(5):1012-22. PMC: 3288519. DOI: 10.1016/j.cellsig.2011.12.022. View

4.
McMahon A, Bradley A . The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell. 1990; 62(6):1073-85. DOI: 10.1016/0092-8674(90)90385-r. View

5.
Wang H, Hao J, Hong C . Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/β-catenin signaling. ACS Chem Biol. 2010; 6(2):192-7. PMC: 3076310. DOI: 10.1021/cb100323z. View